-
Absorption Systems' ACF Bioservices Certified by MHRA
contractpharma
November 27, 2018
Absorption Systems and its ACF Bioservicessubsidiary announced that they have been certified by the European Medicines and Healthcare products Regulatory Agency (MHRA).
-
SEA Vision Launches HarleNir
contractpharma
November 27, 2018
Based on its Harlequin blister control system, HarleNIR is a new generation of blister inspection technology that goes beyond visible inspection to provide a chemical analysis
-
Sun Pharma Acquires Pola Pharma in Japan
contractpharma
November 27, 2018
Sun Pharma has acquired Pola Pharma, a Japanese pharmaceutical company involved in research and development, manufacture, sale and distribution of branded and generic products
-
Oxford BioMedica unveils digital initiative to streamline manufacturing
pharmatimes
November 26, 2018
UK gene and cell therapy group Oxford BioMedica has announced a new digital framework initiative to streamline the production of next-generation medicines.
-
WuXi Biologics Commenced Construction of 1.6 million sq. ft. Biologics Innovation Center in Shanghai
en-cphi.cn
November 22, 2018
WuXi Biologics today announced that construction of a global innovation center has commenced in the district of Fengxian in Shanghai.
-
How can predictive analytics help pharmaceutical manufacturing?
europeanpharmaceuticalreview
November 14, 2018
Predictive analytics can help pharmaceutical companies with better strategies, communication, and ways to meet the needs of end users…
-
Automation could help China’s pharmaceutical manufacturing market
europeanpharmaceuticalreview
November 06, 2018
Automation could help China to become a world leader in the pharmaceutical industry, competing with companies from America and Europe…
-
Patient death following CAR-T therapy highlights serious manufacturing issues
pharmaceutical-technology
October 08, 2018
It is reported that the accidental genetic engineering of a single leukemic cell during the early manufacturing of CAR-T therapy tisagenlecleucel for a phase I study caused the relapse and eventual death of one patient participating in the clinical trial.
-
Novartis to shutter Grimsby site amid manufacturing overhaul
pharmatimes
September 27, 2018
Novartis has announced plans to close its manufacturing site in Grimsby, UK, by the end of 2020, among a wider job cull likely...
-
Pall, Celltheon form Partnership for Biotherapeutics Development and Manufacturing
americanpharmaceuticalreview
September 05, 2018
Pall Corporation has formed a strategic partnership with Celltheon Corporation, an experienced cell line and expression technology platform development company.